Reply to Zhou and Yang: Biological heterogeneity and biomarker-driven personalization: advancing mesenchymal stromal cell therapy for ARDS
Year: 2025
Type: letter
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4415230819
